Sponsored Content

Monoclonal Antibodies and Small-Molecule Drugs: What General Neurologists Need to Know

This content is sponsored by Amgen Inc. and Novartis Pharmaceuticals Corporation.


Click below to learn about monoclonal antibodies and small-molecule drugs, as well as some of the safety implications of their use in general neurology clinical practice.

Click here to read the content.


Next Article: